Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
BioMarin Pharmaceutical Inc.
Tag: BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has coverage initiated with a Outperform rating
ME Staff
-
April 9, 2019
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) had its Buy rating reiterated by Cantor...
ME Staff
-
April 2, 2019
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target raised to $131.00 by Cantor...
ME Staff
-
March 4, 2019
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target lowered to $117.00 by SunTrust...
ME Staff
-
February 25, 2019
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) had its Outperform rating reiterated by Wedbush...
ME Staff
-
February 7, 2019
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target set to $126.00 by Cantor...
ME Staff
-
October 26, 2018
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target raised to $125.00 by Jefferies...
ME Staff
-
October 16, 2018
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target raised to $113.00 by Canaccord...
ME Staff
-
July 31, 2018
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
June 11, 2018
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Files An 8-K Entry into a Material...
ME Staff 8-k
-
November 29, 2017
0
1
2
Page 1 of 2
/* */
// AST – IMS - [MarketExclusive_ROS]